Francine Lane

@FrancineLane

opinions are my own

New York City
Vrijeme pridruživanja: siječanj 2012.

Tweetovi

Blokirali ste korisnika/cu @FrancineLane

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FrancineLane

  1. proslijedio/la je Tweet
    3. velj

    Global recruitment rates have been on the rise over the past seven years, thanks to new techniques designed to make patient participation easier, but the benefits have not translated to patient retention, according to a new study.

    Poništi
  2. proslijedio/la je Tweet
    28. sij

    Check out the first in an 8-part series on transparency policies, by Thomas Wicks, Chief Strategy officer.

    Poništi
  3. proslijedio/la je Tweet
    20. sij

    The degree of digital – of physicians, patients, institutions and payers – can really make the difference between an efficient integration and a missed opportunity, says one communications professional.

    Poništi
  4. proslijedio/la je Tweet
    20. sij

    Failure to report results on distorts evidence, breaches ethical obligations, and represents research waste. See how industry/non-industry, large/small sponsors fared in this comprehensive study.

    Poništi
  5. proslijedio/la je Tweet
    20. sij

    transparency still eludes the system in India, especially for the patient, says the president of the Indian Society for Clinical Research and advocacy groups.

    Poništi
  6. proslijedio/la je Tweet
    20. sij

    Penn State Cancer Institute researchers analyzed data from over 12 million patients with 46 different types of cancer between 2004 and 2015. They found that only 0.1% were enrolled in as their first course of therapy following diagnosis.

    Poništi
  7. proslijedio/la je Tweet
    9. sij

    Australia's University of the Sunshine Coast (USC) has received a $10,000 grant from the Association of Regulatory and Clinical Scientists (ARCS) to conduct a study for creation of a consumer confidence index for the clinical trials industry.

    Poništi
  8. proslijedio/la je Tweet
    7. sij

    Join us, along with EMD Serono - the North America biopharma business of Merck KGaA, Darmstadt, Germany - and CISCRP, for a webinar on how to successfully launch a dedicated website. Register now:

    Poništi
  9. proslijedio/la je Tweet
    7. sij

    are a valuable but often misunderstood part of healthcare, and a stigma still surrounds trials. Who's qualified, risks, costs, length and what's in it for me are the top questions patients ask before deciding whether to participate.

    Poništi
  10. proslijedio/la je Tweet
    19. pro 2019.

    In a joint letter from 33 organizations to the European Medicines Agency, the European Public Health Alliance seeks protection of public access to results. "Full – not secrecy – is the way forward!"

    Poništi
  11. proslijedio/la je Tweet
    16. pro 2019.

    In first-in-class medicines are typically brought to market based on data from majority white, male patients. Among the 53 drugs with U.S. clinical trials in 2018, only 12 had enough data on effects across races, FDA's Snapshots reports.

    Poništi
  12. proslijedio/la je Tweet
    6. pro 2019.

    We join the International Alliance of Patients’ Organizations (IAPO) in celebrating the 7th annual Patient Solidarity Day. Each year, concerned people worldwide rally around and raise awareness for an issue impacting and their families.

    Poništi
  13. 4. pro 2019.

    TrialScope%20Launches%20Clinical%20Trials%20Website%20For%20EMD%20Serono https%3A%2F%%2Fdoc%2Ftrialscope-launches-clinical-trials-website-for-emd-serono-0001

    Poništi
  14. proslijedio/la je Tweet
    4. pro 2019.

    Look for Dave Laky and Lauren Briggs at the DIA Clinical Trial Regulation Conference in Amsterdam. They can answer your questions about clinical trial transparency and disclosure management.

    Poništi
  15. proslijedio/la je Tweet
    25. stu 2019.
    Poništi
  16. proslijedio/la je Tweet
    25. stu 2019.

    The US isn't the only country with gender disparities in - Australian research ignores drugs’ side effects in women. Clinical trials there often fail to report results for sex and gender, although many drugs cause adverse effects in women.

    Poništi
  17. proslijedio/la je Tweet
    22. stu 2019.

    Attending the conferences Dec. 2-5 in Amsterdam? Look for Dave Laky and Lauren Briggs, who will be on hand to answer your questions about automating clinical trial disclosure and making studies more accessible to patients.

    Poništi
  18. proslijedio/la je Tweet
    14. stu 2019.

    A new report shows slow progress in reporting results on CTgov, but data quality still may present a larger problem. Ex-CTgov head Dr. Deborah Zarin shared details of the report at our recent EXTRA: TrialScope Transparency Experience.

    Poništi
  19. proslijedio/la je Tweet
    12. stu 2019.

    The NIH has released a draft policy requiring all investigators with NIH funding to make their data sets available to colleagues. For the first time, grantees holding any NIH-funded grant will need to submit a detailed plan for sharing data.

    Poništi
  20. proslijedio/la je Tweet
    4. stu 2019.

    In a Forbes article, TrialScope CEO Jeff Kozloff gives 5 compelling reasons why transparency is good business. For starters, puts your company in a favorable light with investors. Read all 5 reasons here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·